AstraZeneca said its Covid-19 vaccine sales were $275 million in the first-quarter and it is on track to deliver 200 million doses a month from April, as better-than-expected results and a second half growth forecastboosted its shares.
from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3u99FqR
0 Comments